Spots Global Cancer Trial Database for An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Official Title: An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy, in the First-line Therapy of Recurrent/ Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
Study ID: NCT01142869
Conditions
Interventions
Study Description
Brief Summary: The aim of this prospective, observational, multicenter, post-marketing study is to evaluate the safety and efficacy of Cetuximab (Erbitux) in combination with platinum based chemotherapy, in the first line therapy of recurrent/ metastatic squamous cell carcinoma of head and neck (SCCHN). A total of 100 subjects with SCCHN will be recruited in 20 centres across India.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Ambaa Hospitals, Hyderabad, Andhra Pradesh, India
Indo- American Cancer Institute & Research Centre, Hyderabad, Andhra Pradesh, India
NVS Ramakrishna's Clinic, Hyderabad, Andhra Pradesh, India
Dr. Nikhil's Clinic, Secunderabad, Andhra Pradesh, India
Swarna Sai Hospital, Secunderabad, Andhra Pradesh, India
Sparsh Hospital, Orissa, Bhubaneswar, India
All India Institute of Medical Sciences, New Delhi, Delhi, India
Wellness Consultants Clinic, Surat, Gujarat, India
Global Health Pvt Ltd, Gurgaon, Haryana, India
The Cancer Clinic, Kochin, Kerala, India
Dr. T. P. Sahoo's Clinic, Bhopal, Madhya Pradesh, India
BND Onco Centre, Mumbai, Maharashtra, India
S.L.Raheja Hospital, Mumbai, Maharashtra, India
S M Karandikar's Clinic, Pune, Maharashtra, India
Ruby Hall Clinic, Pune, Maharashtra, India
Galaxy Care Laproscopic Institute, Pune, Maharashtra, India
Neigrihms, Shillong, Meghalaya, India
Grace Nursing Home, Aizwal, Mizoram, India
Cancer Clinic, Jaipur, Rajasthan, India
SMS Hospital, Jaipur, Rajasthan, India
Bhagwan Mahaveer Cancer Hospital, Jaipur, Rajasthan, India
J.K.Cancer Institute, Kanpur, Uttar Pradesh, India
Annapurna Medical and Cancer Relief Society, Lucknow, Uttar Pradesh, India
Dr. Vineet's Clinic, New Delhi, Uttar Pradesh, India
SMH-Curie Cancer Centre, Shanti Mukand Hospital, New Delhi, Uttar Pradesh, India
Apollo Gleneagles Cancer Hospital, Kolkata, West Bengal, India
B.R. Singh Hospital, Kolkatta, West Bengal, India
Sunil Gupta's Clinic, Delhi, , India
Contact Details
Name: Dr. Rajiv Rana
Affiliation: Merck Ltd., India
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
